Ligand validation:9EIZ

OXL: OXALATE ION

OXL is a Ligand Of Interest in 9EIZ designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9EIZ_OXL_A_704	83%	12%	0.075	0.934	2	2.06	2	2	0	0	100%	1
3DT2_OXL_A_800	99%	25%	0.06	0.989	1.55	1.52	1	2	0	0	100%	1
4GNQ_OXL_A_705	98%	29%	0.054	0.978	1.3	1.54	-	1	0	0	100%	1
9EJ0_OXL_A_704	98%	9%	0.051	0.97	2.31	2.13	2	2	0	0	100%	1
5V9G_OXL_A_704	95%	25%	0.082	0.985	1.88	1.17	2	-	0	0	100%	1
4GNM_OXL_A_706	94%	14%	0.067	0.968	2.01	1.84	2	2	0	0	100%	1
3CV2_OXL_A_1000	100%	10%	0.017	0.998	2.52	1.88	1	2	0	0	100%	1
9R3L_OXL_A_601	100%	26%	0.021	0.996	1.89	1.12	2	1	1	0	100%	1
9O3B_OXL_F_603	100%	19%	0.025	0.994	1.76	1.69	2	2	0	0	100%	1
1PT8_OXL_B_801	100%	9%	0.036	0.993	2.35	2.09	1	2	0	0	100%	1
1PZH_OXL_A_702	100%	21%	0.047	0.988	2.03	1.3	2	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.